-transparent.png){kind=logo}
A patient is presented who developed ventricular fibrillation following AMSA treatment, in the setting of hypokalemia. Resuscitation was successful, chemotherapy treatment response was observed, and further treatment with AMSA was uncomplicated after correction of the hypokalemia. With careful attention to electrolyte balance, a prior history of AMSA-induced cardiac arrhythmia does not contraindicate further treatment with AMSA.
Related Publications
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
January 1982,
Annals of internal medicine,
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
February 2012,
The Journal of emergency medicine,
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
October 2015,
Circulation,
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
January 1983,
Cancer treatment reports,
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
December 2005,
Pacing and clinical electrophysiology : PACE,
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
December 1982,
JAMA,
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
February 1984,
Wiadomosci lekarskie (Warsaw, Poland : 1960),
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
January 2003,
Circulation journal : official journal of the Japanese Circulation Society,
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
August 2012,
Pacing and clinical electrophysiology : PACE,
P McLaughlin, and
P G Salvador, and
F Cabanillas, and
S S Legha
January 2016,
European journal of case reports in internal medicine,
